Copaxone

Teva's trial in high-stakes kickbacks case delayed as company pursues rare pretrial appeal
Teva's trial in high-stakes kickbacks case delayed as company pursues rare pretrial appeal
Fierce Pharma
Teva Pharmaceutical
kickbacks
Copaxone
MS
multiple sclerosis
Flag link:
Facing potential $10B trial loss, Teva seeks appeal of recent ruling in kickbacks case
Facing potential $10B trial loss, Teva seeks appeal of recent ruling in kickbacks case
Fierce Pharma
Teva Pharmaceutical
legal
kickbacks
Copaxone
Flag link:
Teva abused patent system and spread misinformation about a Copaxone rival, European officials say
Teva abused patent system and spread misinformation about a Copaxone rival, European officials say
Fierce Pharma
Teva Pharmaceutical
Europe
Copaxone
legal
pharma marketing
Flag link:
J&J's Momenta calls infringement against Viatris' Copaxone generic, but why now?
J&J's Momenta calls infringement against Viatris' Copaxone generic, but why now?
Fierce Pharma
JNJ
Momenta Pharmaceuticals
Viatris
Copaxone
generics
drug manufacturing
Flag link:
Court denies Teva's motion to dismiss Copaxone kickbacks case
Court denies Teva's motion to dismiss Copaxone kickbacks case
Globes, Israel
Teva Pharmaceutical
Copaxone
Medicare
False Claims Act
Flag link:
Mylan sues generic rival Teva over 'sophisticated scheme' to block Copaxone copycats
Mylan sues generic rival Teva over 'sophisticated scheme' to block Copaxone copycats
Fierce Pharma
Teva Pharmaceutical
Mylan
Viatris
MS
generics
Copaxone
Flag link:
Congressional investigation reveals Celgene, Teva plotted to keep drug prices high
Congressional investigation reveals Celgene, Teva plotted to keep drug prices high
RAPS.org
congress
Celgene
Teva Pharmaceutical
Revlimid
Copaxone
drug pricing
Flag link:
'Uninhibited' price hikes, lobbying and more: Congressional probe gives detailed look into Teva's long run with Copaxone
'Uninhibited' price hikes, lobbying and more: Congressional probe gives detailed look into Teva's long run with Copaxone
Fierce Pharma
Teva Pharmaceutical
Copaxone
congress
MS
drug pricing
competition
Flag link:
Teva shares slide as it faces illegal kickback charges from US government
Teva shares slide as it faces illegal kickback charges from US government
Pharmaforum
Teva Pharmaceutical
kickbacks
DOJ
Copaxone
MS
multiple sclerosis
Flag link:
U.S. sues Teva over alleged kickbacks for multiple sclerosis drug
U.S. sues Teva over alleged kickbacks for multiple sclerosis drug
Reuters
Teva Pharmaceutical
Copaxone
kickbacks
Medicare
Flag link:
Teva Calls on FDA to Make Copaxone a Biologic as Part of March Transition
Teva Calls on FDA to Make Copaxone a Biologic as Part of March Transition
RAPS.org
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
FDA
biologics
Flag link:
Teva forks over $54M to settle Copaxone, Azilect kickbacks suit
Teva forks over $54M to settle Copaxone, Azilect kickbacks suit
Fierce Pharma
Teva Pharmaceutgical
Copaxone
Azilect
kickbacks
whistleblower lawsuit
Flag link:
Teva shares approach 20-year low amid Moody’s warning and other woes
Teva shares approach 20-year low amid Moody’s warning and other woes
Fierce Pharma
Teva Pharmaceutical
Copaxone
opioids
Flag link:
Dr. Reddy's Copaxone, NuvaRing generics derailed by FDA
Dr. Reddy's Copaxone, NuvaRing generics derailed by FDA
Fierce Pharma
FDA
Dr Reddy's
Copaxone
Teva Pharmaceutical
generics
Merck
Nuvaring
Flag link:
Teva predicts bleak year ahead as generic, Copaxone sales drop
Teva predicts bleak year ahead as generic, Copaxone sales drop
Biopharma Dive
Teva Pharmaceutical
Copaxone
Flag link:
Mylan's generic Copaxone wins in court, but market barriers remain
Mylan's generic Copaxone wins in court, but market barriers remain
Biopharma Dive
Teva Pharmaceutical
Copaxone
patents
MS
multiple sclerosis
Flag link:
Here's Why Momenta Pharmaceuticals Tumbled 13.5% on Friday
Here's Why Momenta Pharmaceuticals Tumbled 13.5% on Friday
Motley Fool
Momenta Pharmaceuticals
Teva Pharmaceuticals
Copaxone
Novartis
biosimilars
Glatopa
Flag link:
Gilenya beats Copaxone head-to-head at higher dose, study finds
Gilenya beats Copaxone head-to-head at higher dose, study finds
Biopharma Dive
Novartis
Teva Pharmaceutical
MS
Copaxone
Gilenya
Flag link:
Teva scoffs at whistleblowers' evidence in bid to dismiss kickbacks case
Teva scoffs at whistleblowers' evidence in bid to dismiss kickbacks case
Fierce Pharma
Teva Pharmaceutical
Copaxone
Azilect
kickbacks
generics
whistleblowers
Flag link:
Teva stock drops 4.5% in spite of Q2 profit beat, revenue match
Teva stock drops 4.5% in spite of Q2 profit beat, revenue match
Marketwatch
Teva Pharmaceutical
earnings
Copaxone
Flag link:

Pages